1. Home
  2. ALLO vs PSNYW Comparison

ALLO vs PSNYW Comparison

Compare ALLO & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$0.76

Market Cap

452.6M

Sector

Health Care

ML Signal

HOLD

Logo Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

PSNYW

Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

SELL

Current Price

$2.80

Market Cap

501.1M

ML Signal

SELL

Company Overview

Basic Information
Metric
ALLO
PSNYW
Founded
2017
2017
Country
United States
Sweden
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
452.6M
501.1M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ALLO
PSNYW
Price
$0.76
$2.80
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $9.00
N/A
AVG Volume (30 Days)
★ 11.2M
30.3K
Earning Date
11-05-2026
03-06-2025
Dividend Yield
N/A
N/A
EPS Growth
★ 34.09
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.02
$79.49
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.74
$0.20
52 Week High
$4.46
$9.08

Technical Indicators

Market Signals
Indicator
ALLO
PSNYW
Relative Strength Index (RSI) 21.26 41.13
Support Level N/A $2.88
Resistance Level $2.25 $3.45
Average True Range (ATR) 0.10 0.34
MACD -0.02 0.02
Stochastic Oscillator 0.42 10.85

Price Performance

Historical Comparison
ALLO
PSNYW

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

Share on Social Networks: